China SXT PharmaceuticalsSXTC +2.98%26 Pretax Margin % is -1,015.79% as of Sep. 2025. GuruFocus rates SXTC with a GF Score™ of 26/100. The stock has 5 warning signs investors should review. Among 952 Drug Manufacturers companies, China SXT Pharmaceuticals ranks worse than 95.69% on this metric.
The historical rank and industry rank for China SXT Pharmaceuticals's Pretax Margin % or its related term are showing as below:
SXTC'
s Pretax Margin % Range Over the Past 10 Years
Min: -576.72 Med: -160.74 Max: 32.36
Current: -576.72
SXTC's Pretax Margin % is ranked worse than 95.69% of 952
companies
in the Drug Manufacturers industry
Industry Median: 7.295
vs SXTC: -576.72
China SXT Pharmaceuticals (NAS:SXTC) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
China SXT Pharmaceuticals Pretax Margin % Related Terms
China SXT Pharmaceuticals Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SXTC vs YCBD, CVSI, INM: Pretax Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
China SXT Pharmaceuticals Pretax Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where China SXT Pharmaceuticals's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China SXT Pharmaceuticals (SXTC) has a Pretax Margin % of -1,015.79% as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on China SXT Pharmaceuticals and its competitors. According to the industry distribution chart, China SXT Pharmaceuticals ranks #911 out of 952 companies in the Drug Manufacturers industry, placing it in the top 95.7%.
Is China SXT Pharmaceuticals' Pretax Margin % too high?
China SXT Pharmaceuticals' current Pretax Margin % is -1,015.79%. Based on the distribution chart, China SXT Pharmaceuticals ranks #911 out of 952 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, China SXT Pharmaceuticals has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does China SXT Pharmaceuticals' Pretax Margin % compare to YCBD and CVSI?
According to the Drug Manufacturers industry distribution chart, China SXT Pharmaceuticals ranks #911 out of 952 companies for Pretax Margin %. This places China SXT Pharmaceuticals in the lower half of its industry. The industry median Pretax Margin % is 7.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Drug Manufacturers company?
The median Pretax Margin % among Drug Manufacturers companies is 7.30, based on 952 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on China SXT Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Pretax Margin % is 7.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China SXT Pharmaceuticals's current Pretax Margin % is -1,015.79%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China SXT Pharmaceuticals stock overvalued right now?
China SXT Pharmaceuticals (SXTC) has a current Pretax Margin % of -1,015.79%. The current Pretax Margin % is -1,015.79%. China SXT Pharmaceuticals' overall GF Score™ is 26/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For China SXT Pharmaceuticals (SXTC), the current Pretax Margin % is -1,015.79% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.
26GF Score
Get the complete analysis for SXTC
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SXTC has been successfully added to your 
